Navigation Links
Wolters Kluwer Pharma Solutions Names Henry Prolog Vice President of Data Strategy, Acquisitions & Services
Date:9/8/2011

PHOENIX, Sept. 8, 2011 /PRNewswire/ -- Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics to pharmaceutical and healthcare professionals, today announced the appointment of Henry Prolog as Vice President, Data Strategy, Acquisitions & Services.  Prolog brings more than 25 years of sales, data contracts, and marketing experience in the healthcare, technology and information industries. "Hank will help us evolve vendor relationships into true partnerships that will fulfill our customer, partner and stakeholder needs," said Michelle Woker, President & Chief Operating Officer, Healthcare Analytics, Wolters Kluwer Pharma Solutions.  "This role is key to our strategy going forward, and Hank's myriad of experience will help us achieve both our short and long term goals."

Prior to joining Wolters Kluwer Pharma Solutions, Prolog held several senior management roles in related industries, including Siemens Medical, Fresenius USA, IMS Health, Verispan and US Oncology.  

Most recently, Prolog was with US Oncology in Houston, where he was National Director, Channels, in charge of managing partnerships and alliances for the Informatics Division.  He also spent a decade at Verispan as Regional Vice President of Sales; and was Group Director, Marketing, Service and Sales, at IMS Health in Blue Bell, Pa.  He also held a Director of Sales and Marketing role at Fresenius USA in New Brunswick, N.J.; and started his illustrious healthcare information career as Manager of International Sales at Siemens Medical, Iselin, N.J., where he managed sales teams in Europe, Asia and South America.

In his new role, Prolog will manage the supply of data and information sets from PBM's, wholesalers, retail pharmacies and hospitals.  He is responsible for setting data strategy for the company's healthcare analytics business.  He also will determine the data agreements necessary to support top line revenue growth.  Most importantly, he will continue to develop relationships with management executives from current and prospective data suppliers. 

Prolog holds a B.A. from Montclair State College in Montclair, N.J. and an M.B.A. from the University of Munich in Munich, Germany.  He will be based near the company's Yardley, Pa. office and will report directly to Michelle Woker, President & COO, Healthcare Analytics, in Phoenix. 

For more information, visit the company's website at www.wolterskluwerpharma.com.

About Wolters Kluwer Pharma SolutionsWolters Kluwer Pharma Solutions, Inc. (Phoenix, AZ and Yardley, PA) is a leading provider of information and analytics to the pharmaceutical, biotech, and medical device industries. The company's brands include Adis, Source® and Lippincott Williams & Wilkins. A provider of business intelligence and services, Adis publishes 19 peer-reviewed drug research journals and 2 newsletters and offers the most respected drug and clinical trials databases in the pharma industry. Lippincott Williams & Wilkins (LWW) is a leading international healthcare publisher with nearly 300 periodicals and 1,500 books in more than 100 disciplines. A longstanding provider of market data and healthcare analytics, Source® offers a unique set of comprehensive patient and physician-level prescribing and usage data. For more information, visit www.wolterskluwerpharma.com.

The company is a wholly owned subsidiary of Wolters Kluwer, U.S., part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer's leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer has 2010 annual revenues of EUR3.6 billion ($4.7 billion), employs approximately 18,200 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.Contact:

Tom KivettKivett & Company Communications(212) 727-2935tkivett@kivettandco.com
'/>"/>

SOURCE Wolters Kluwer Pharma Solutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources
2. Wolters Kluwer Health Completes Acquisition of Pharmacy OneSource
3. Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom
4. Wolters Kluwer Health to Acquire Leading Global Drug Information Provider Lexi-Comp
5. Wolters Kluwer Health Completes Acquisition of Lexi-Comp, Inc.
6. Congressman Quayle Talks With Wolters Kluwer Pharma Solutions About Importance of Health Information
7. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):